Noninfectious aortitis: Experience with tocilizumab in a regional hospital

Objectives Describe patients with noninfectious aortitis and their response to treatment in a regional hospital. Methods Review of patients with noninfectious aortitis, diagnostic technique used and immunosuppressive therapy received. Results We report 8 patients (7 women and one man) diagnosed with aortitis by positron emission tomography (PET). The mean age was 69 years (interquartile range [IQR] 62–72.2). Three months of treatment with tocilizumab improved symptoms, erythrocyte sedimentation rate and C -reactive protein level (P Conclusions Tocilizumab was an effective and safe treatment in those patients diagnosed with aortitis refractory to steroids and conventional immunosuppressive therapy.